Diagnosis typically involves a combination of molecular testing and imaging studies. Molecular testing can identify the presence of IDH2 mutations, which can be done using techniques such as polymerase chain reaction (PCR) or next-generation sequencing (NGS). Imaging studies like MRI and CT scans help visualize tumors and assess their extent.
